Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Advisory Board Member Presented at CannMed 2017 Personalized Cannabinoid Medicine Conference at Harvard
April 13, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, April 13, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that Dr. Ilya Reznik, a...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome With CanChew Plus® Cannabidiol (CBD) Chewing Gum
March 07, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, March 07, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced enrollment of 40 patients...
Axim-Sapphire_Logo_-04 (1).png
AXIM Biotech Announces the Production of CanChew Plus™, the Next Generation Controlled Release CBD Chewing Gum
March 01, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, March 01, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, began production of CanChew Plus™, the next...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum
January 18, 2017 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating...
Axim-Sapphire_Logo_-04 (1).png
AXIM® Biotech Receives Medical Ethical Committee Approval to Begin IBS Trial for Canchew Plus® CBDGum
December 06, 2016 09:00 ET | AXIM Biotechnologies, Inc
NEW YORK, Dec. 06, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it received...
Photo Release -- AXIM Biotechnologies Adds Health Industry Senior Marketing Executive Joe Grace to Advisory Board
August 26, 2015 09:00 ET | AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 26, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is proud to announce the latest appointment to its Board of Advisors: Mr. Joe Grace. A proven business and marketing...
Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences
June 04, 2015 09:00 ET | AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, June 4, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...
Photo Release -- Patent for World's First Cannabinoid Release Gum Awarded to Medical Marijuana, Inc.'s Joint Venture Partner -- CanChew Biotechnologies, LLC
May 27, 2015 09:00 ET | Medical Marijuana Inc
SAN DIEGO, May 27, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA), a leading industrial hemp industry innovator, is proud to announce that its joint venture partner, CanChew...